September 25, 2015
Bayer: Factor Xa inhibitor Xarelto approved in Japan
The Japanese Ministry of Health, Labor and Welfare (MHLW) has approved in Japan Bayer’s oral Factor Xa inhibitor Xarelto (rivaroxaban) for the treatment…
Pharmaceuticals, Biotechnology and Life Sciences
The Japanese Ministry of Health, Labor and Welfare (MHLW) has approved in Japan Bayer’s oral Factor Xa inhibitor Xarelto (rivaroxaban) for the treatment…
Bayer announced on September 22 that Bayer CropScience and the civil organization Round Table on Responsible (RTRS) are uniting to…
The Supervisory Board of Bayer has approved the reorganization proposed by the Board of Management, so that from January 1,…
You must be logged in to post a comment.